Averion Expands Operations to Europe and Names John Shillingford, PhD as President of New Wholly-Owned Subsidiary Averion GmbH

Business Wire, May 23, 2006

FRAMINGHAM, Mass. -- Averion Inc. announced today its expansion into Europe through the creation of Averion GmbH, a new wholly-owned subsidiary based in Germany. The Company also announced the appointment of John Shillingford, PhD as President of Averion GmbH.

"We are very excited to have John joining us and leading Averion's expansion into Europe," said Philip T. Lavin, PhD, President and CEO of Averion Inc., "This will enable Averion to better serve our USA clients seeking to conduct clinical trials using European sites and to serve the ever expanding European marketplace in pharmaceuticals, biotechnology, and medical devices. John brings a unique combination of exceptional management and operations credentials."

John will oversee the operations of Averion GmbH, inclusive of recruiting new European clients as well as running trials for Averion's existing North American customers. He joins Averion with 25 years of Pharmaceutical and Contract Research industry experience both in the United States and Europe giving him a firm global understanding of what is needed to effectively conduct clinical trials internationally. He has most recently held positions in overseeing Clinical Operations and Project Management responsibilities at PRA International and ImForm GmbH.

Averion GmbH will work to develop relationships with European clients as well as run European studies for existing North American clients. The new subsidiary will offer Averion's full range of services including: Auditing, Biometrics, Clinical Monitoring, Clinical Project Management, Compliance and Validation, Database Development, Data Management, Data Monitoring and Clinical Endpoint Committees, Medical Monitoring, Medical Writing, Metrics Consulting, Pharmacovigilance, Program Planning/Study Design and Regulatory Consulting.

About Averion:

Averion provides clinical trials support for pharmaceutical, biotechnology and medical device companies in the design, execution and reporting of clinical trials. Services include: Auditing, Biometrics, Clinical Monitoring, Clinical Project Management, Compliance and Validation, Database Development, Data Management, Data Monitoring and Clinical Endpoint Committees, Medical Monitoring, Medical Writing, Metrics Consulting, Pharmacovigilance, Program Planning/Study Design and Regulatory Consulting.

Averion's corporate headquarters are located in Framingham, Massachusetts.

Visit Averion's website at www.averioninc.com.